These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12616468)

  • 1. Interobserver variability in determining MIB-1 labeling indices in oligodendrogliomas.
    Prayson RA; Castilla EA; Hembury TA; Liu W; Noga CM; Prok AL
    Ann Diagn Pathol; 2003 Feb; 7(1):9-13. PubMed ID: 12616468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods.
    Hsu CY; Ho DM; Yang CF; Chiang H
    Mod Pathol; 2003 Sep; 16(9):951-7. PubMed ID: 13679460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
    Majumdar K; Radotra BD; Vasishta RK; Pathak A
    Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 in oligodendroglial neoplasms.
    Castilla EA; Prayson RA; Kanner AA; Rybicki LA; Tubbs RR; Vogelbaum MA; Barnett GH
    Cancer; 2003 Oct; 98(7):1465-72. PubMed ID: 14508834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma.
    Nishi T; Kuratsu J; Takeshima H; Saito Y; Kochi M; Ushio Y
    Int J Mol Med; 1999 Feb; 3(2):157-61. PubMed ID: 9917523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
    Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A
    Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver variability associated with the MIB-1 labeling index: high levels suggest limited prognostic usefulness for patients with primary brain tumors.
    Grzybicki DM; Liu Y; Moore SA; Brown HG; Silverman JF; D'Amico F; Raab SS
    Cancer; 2001 Nov; 92(10):2720-6. PubMed ID: 11745208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
    Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer.
    Neri A; Marrelli D; Pedrazzani C; Caruso S; De Stefano A; Mariani F; Megha T; De Marco G; Corso G; Pinto E; Roviello F
    Eur J Surg Oncol; 2008 Dec; 34(12):1299-303. PubMed ID: 18164172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
    Preusser M; Wolfsberger S; Czech T; Slavc I; Budka H; Hainfellner JA
    Am J Clin Pathol; 2005 Oct; 124(4):543-9. PubMed ID: 16146813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas.
    Maiuri F; Del Basso De Caro ML; Iaconetta G; Peca C; Esposito M; de Divitiis E
    Zentralbl Neurochir; 2006 Nov; 67(4):204-9. PubMed ID: 17106834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of labeling index of DNA polymerase alpha in human brain tumors. Comparative study with labeling indices of BUdR in vitro and Ki-67.
    Nishizaki T; Orita T; Kamiryo T; Akimura T; Kajiwara K; Ikeda N; Ohshita N; Ito H; Sasaki K
    Clin Neuropathol; 1993; 12(3):160-3. PubMed ID: 8324965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement.
    Frank I; Cheville JC; Blute ML; Lohse CM; Karnes RJ; Weaver AL; Sebo TJ; Nehra A; Zincke H
    Cancer; 2004 Oct; 101(8):1803-8. PubMed ID: 15386300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
    Walts AE; Lechago J; Bose S
    Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of dUTPase in intracranial tumors.
    Romeike BF; Böckeler A; Kremmer E; Sommer P; Krick C; Grässer F
    Pathol Res Pract; 2005; 201(11):727-32. PubMed ID: 16325515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observer reliability in assessment of mitotic activity and MIB-1-determined proliferation rate in pediatric sarcomas.
    Molenaar WM; Plaat BE; Berends ER; te Meerman GJ
    Ann Diagn Pathol; 2000 Aug; 4(4):228-35. PubMed ID: 10982300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
    Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
    J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
    Brustmann H
    Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.